| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 4.11e-07 | 5 | 70 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | superoxide-generating NADPH oxidase activator activity | 4.86e-06 | 10 | 70 | 3 | GO:0016176 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 8.87e-06 | 12 | 70 | 3 | GO:0016175 | |
| GeneOntologyMolecularFunction | ribonucleoside-diphosphate reductase activity | 3.63e-05 | 3 | 70 | 2 | GO:0061731 | |
| GeneOntologyMolecularFunction | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 3.63e-05 | 3 | 70 | 2 | GO:0004748 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 4.51e-05 | 20 | 70 | 3 | GO:0050664 | |
| GeneOntologyMolecularFunction | enzyme activator activity | ARHGDIA TBC1D15 PSME4 NCF1 RICTOR RABGAP1 AGAP9 NCF1C NCF1B CTSK | 9.17e-05 | 656 | 70 | 10 | GO:0008047 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor | 1.20e-04 | 5 | 70 | 2 | GO:0016728 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 2.49e-04 | 35 | 70 | 3 | GO:0043325 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 3.47e-04 | 95 | 70 | 4 | GO:0016651 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | ARHGDIA TBC1D15 PSME4 NCF1 RICTOR RABGAP1 EPS8L3 AGAP9 LYN NCF1C NCF1B CTSK SERPINA9 NOS1AP | 3.48e-04 | 1418 | 70 | 14 | GO:0030234 |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 5.35e-04 | 10 | 70 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 1.24e-03 | 15 | 70 | 2 | GO:0016725 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 1.60e-03 | 143 | 70 | 4 | GO:0017124 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 2.21e-03 | 20 | 70 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.26e-03 | 262 | 70 | 5 | GO:0140097 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of gram-positive bacterium | 3.89e-07 | 5 | 71 | 3 | GO:0070946 | |
| GeneOntologyBiologicalProcess | NADP catabolic process | 1.35e-06 | 7 | 71 | 3 | GO:0006742 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of fungus | 1.35e-06 | 7 | 71 | 3 | GO:0070947 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst involved in inflammatory response | 6.32e-06 | 11 | 71 | 3 | GO:0060264 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in inflammatory response | 1.09e-05 | 13 | 71 | 3 | GO:0002536 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of bacterium | 2.12e-05 | 16 | 71 | 3 | GO:0070944 | |
| GeneOntologyBiologicalProcess | response to yeast | 3.07e-05 | 18 | 71 | 3 | GO:0001878 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of symbiont cell | 3.64e-05 | 19 | 71 | 3 | GO:0070943 | |
| GeneOntologyBiologicalProcess | NADP metabolic process | 4.14e-05 | 56 | 71 | 4 | GO:0006739 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in defense response | 4.27e-05 | 20 | 71 | 3 | GO:0002679 | |
| GeneOntologyBiologicalProcess | neutrophil mediated cytotoxicity | 4.97e-05 | 21 | 71 | 3 | GO:0070942 | |
| GeneOntologyBiologicalProcess | negative regulation of smooth muscle contraction | 5.74e-05 | 22 | 71 | 3 | GO:0045986 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide biosynthetic process | 5.74e-05 | 22 | 71 | 3 | GO:0050665 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst | 6.59e-05 | 23 | 71 | 3 | GO:0060263 | |
| GeneOntologyBiologicalProcess | production of molecular mediator involved in inflammatory response | 9.57e-05 | 133 | 71 | 5 | GO:0002532 | |
| GeneOntologyBiologicalProcess | meiosis I | 1.53e-04 | 147 | 71 | 5 | GO:0007127 | |
| GeneOntologyBiologicalProcess | meiosis I cell cycle process | 1.96e-04 | 155 | 71 | 5 | GO:0061982 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle G2/M phase transition | 1.98e-04 | 33 | 71 | 3 | GO:1902751 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle contraction | 2.36e-04 | 35 | 71 | 3 | GO:0045932 | |
| GeneOntologyBiologicalProcess | germ cell development | 2.46e-04 | 482 | 71 | 8 | GO:0007281 | |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 2.57e-04 | 36 | 71 | 3 | GO:0007274 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | 2.83e-04 | 767 | 71 | 10 | GO:0055086 | |
| GeneOntologyBiologicalProcess | spermatid development | 2.85e-04 | 262 | 71 | 6 | GO:0007286 | |
| GeneOntologyBiologicalProcess | killing by host of symbiont cells | 3.02e-04 | 38 | 71 | 3 | GO:0051873 | |
| GeneOntologyBiologicalProcess | positive regulation of G0 to G1 transition | 3.23e-04 | 8 | 71 | 2 | GO:0070318 | |
| GeneOntologyBiologicalProcess | replication-born double-strand break repair via sister chromatid exchange | 3.23e-04 | 8 | 71 | 2 | GO:1990414 | |
| GeneOntologyBiologicalProcess | spermatid differentiation | 3.48e-04 | 272 | 71 | 6 | GO:0048515 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 3.79e-04 | 41 | 71 | 3 | GO:0006691 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 4.08e-04 | 42 | 71 | 3 | GO:0070316 | |
| GeneOntologyBiologicalProcess | respiratory burst | 4.37e-04 | 43 | 71 | 3 | GO:0045730 | |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | 4.46e-04 | 527 | 71 | 8 | GO:0022412 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 4.68e-04 | 44 | 71 | 3 | GO:0045023 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | 5.46e-04 | 684 | 71 | 9 | GO:0009117 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | 5.88e-04 | 691 | 71 | 9 | GO:0006753 | |
| GeneOntologyBiologicalProcess | neutrophil mediated immunity | 6.05e-04 | 48 | 71 | 3 | GO:0002446 | |
| GeneOntologyBiologicalProcess | superoxide anion generation | 6.82e-04 | 50 | 71 | 3 | GO:0042554 | |
| GeneOntologyBiologicalProcess | deoxyribose phosphate metabolic process | 9.51e-04 | 56 | 71 | 3 | GO:0019692 | |
| GeneOntologyBiologicalProcess | deoxyribonucleotide metabolic process | 1.00e-03 | 57 | 71 | 3 | GO:0009262 | |
| GeneOntologyCellularComponent | oxidoreductase complex | 1.80e-05 | 161 | 71 | 6 | GO:1990204 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 2.95e-05 | 18 | 71 | 3 | GO:0043020 | |
| GeneOntologyCellularComponent | ribonucleoside-diphosphate reductase complex | 3.40e-05 | 3 | 71 | 2 | GO:0005971 | |
| GeneOntologyCellularComponent | apical cytoplasm | 6.79e-05 | 4 | 71 | 2 | GO:0090651 | |
| GeneOntologyCellularComponent | manchette | 1.16e-04 | 28 | 71 | 3 | GO:0002177 | |
| GeneOntologyCellularComponent | meiotic cohesin complex | 2.36e-04 | 7 | 71 | 2 | GO:0030893 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 4.17e-04 | 185 | 71 | 5 | GO:0009898 | |
| GeneOntologyCellularComponent | cohesin complex | 6.13e-04 | 11 | 71 | 2 | GO:0008278 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.11e-03 | 230 | 71 | 5 | GO:0098562 | |
| HumanPheno | Lupus anticoagulant | 3.61e-06 | 7 | 25 | 3 | HP:0025343 | |
| MousePheno | abnormal angiotensin I-converting enzyme activity | 1.21e-06 | 6 | 56 | 3 | MP:0013254 | |
| MousePheno | increased angiotensin I-converting enzyme activity | 1.21e-06 | 6 | 56 | 3 | MP:0003184 | |
| MousePheno | liver abscess | 2.11e-06 | 7 | 56 | 3 | MP:0003332 | |
| MousePheno | impaired granulocyte bactericidal activity | 7.16e-06 | 10 | 56 | 3 | MP:0005074 | |
| MousePheno | decreased susceptibility to Orthomyxoviridae infection | 4.76e-05 | 18 | 56 | 3 | MP:0020947 | |
| MousePheno | ectopic manchette | 5.64e-05 | 19 | 56 | 3 | MP:0009377 | |
| MousePheno | detached sperm flagellum | 7.70e-05 | 21 | 56 | 3 | MP:0008893 | |
| MousePheno | decreased vasoconstriction | 8.88e-05 | 22 | 56 | 3 | MP:0003026 | |
| MousePheno | increased circulating renin level | 1.02e-04 | 23 | 56 | 3 | MP:0003352 | |
| MousePheno | abnormal circulating renin level | 2.07e-04 | 29 | 56 | 3 | MP:0003349 | |
| MousePheno | increased Harderian gland tumor incidence | 2.34e-04 | 6 | 56 | 2 | MP:0012437 | |
| MousePheno | oxidative stress | 3.48e-04 | 152 | 56 | 5 | MP:0003674 | |
| MousePheno | impaired smooth muscle contractility | 3.64e-04 | 35 | 56 | 3 | MP:0000740 | |
| MousePheno | granulomatous inflammation | 3.96e-04 | 36 | 56 | 3 | MP:0002500 | |
| Domain | SH3 | 1.62e-05 | 216 | 70 | 7 | SM00326 | |
| Domain | SH3 | 1.62e-05 | 216 | 70 | 7 | PS50002 | |
| Domain | SH3_domain | 1.83e-05 | 220 | 70 | 7 | IPR001452 | |
| Domain | Rad21/Rec8_C_eu | 4.14e-05 | 3 | 70 | 2 | IPR006909 | |
| Domain | Rad21_Rec8_N | 4.14e-05 | 3 | 70 | 2 | IPR006910 | |
| Domain | - | 4.14e-05 | 3 | 70 | 2 | 1.10.10.580 | |
| Domain | Rad21_Rec8_N | 4.14e-05 | 3 | 70 | 2 | PF04825 | |
| Domain | Rad21_Rec8 | 4.14e-05 | 3 | 70 | 2 | PF04824 | |
| Domain | Rad21/Rec8_C | 4.14e-05 | 3 | 70 | 2 | IPR023093 | |
| Domain | SLC35_F1/F2/F6 | 8.27e-05 | 4 | 70 | 2 | IPR009262 | |
| Domain | SLC35F | 8.27e-05 | 4 | 70 | 2 | PF06027 | |
| Domain | SH3_2 | 3.05e-04 | 86 | 70 | 4 | IPR011511 | |
| Domain | SH3_2 | 3.05e-04 | 86 | 70 | 4 | PF07653 | |
| Domain | - | 1.81e-03 | 746 | 70 | 9 | 3.40.50.300 | |
| Domain | SH3_9 | 3.14e-03 | 78 | 70 | 3 | PF14604 | |
| Domain | P-loop_NTPase | 4.27e-03 | 848 | 70 | 9 | IPR027417 | |
| Domain | PID | 4.91e-03 | 28 | 70 | 2 | PF00640 | |
| Domain | PH_dom-like | 5.21e-03 | 426 | 70 | 6 | IPR011993 | |
| Domain | PID | 6.39e-03 | 32 | 70 | 2 | PS01179 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES | 4.15e-06 | 9 | 53 | 3 | MM14524 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 9.35e-06 | 76 | 53 | 5 | MM14526 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 2.58e-05 | 46 | 53 | 4 | MM15837 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 1.09e-04 | 25 | 53 | 3 | MM15269 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | PSME4 ARPC1A NCF1 PSMD13 PLD3 NKIRAS2 LYN NCF1C NCF1B CTSK CAP1 DERA | 2.56e-04 | 995 | 53 | 12 | MM14661 |
| Pathway | BIOCARTA_FMLP_PATHWAY | 2.77e-04 | 34 | 53 | 3 | MM1399 | |
| Pathway | REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES | 3.02e-04 | 35 | 53 | 3 | MM14944 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 3.15e-04 | 87 | 53 | 4 | MM15600 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS | 3.46e-04 | 162 | 53 | 5 | MM15688 | |
| Pathway | REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES | 3.86e-04 | 38 | 53 | 3 | MM14519 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 4.06e-04 | 93 | 53 | 4 | MM15609 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 4.93e-04 | 175 | 53 | 5 | MM15599 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 5.98e-04 | 103 | 53 | 4 | MM14752 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 18036262 | ||
| Pubmed | Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice. | 8.87e-09 | 3 | 73 | 3 | 10678931 | |
| Pubmed | Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome. | 8.87e-09 | 3 | 73 | 3 | 27044504 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 17167081 | ||
| Pubmed | Mice lacking NCF1 exhibit reduced growth of implanted melanoma and carcinoma tumors. | 8.87e-09 | 3 | 73 | 3 | 24358335 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 10891396 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 25474113 | ||
| Pubmed | NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. | 8.87e-09 | 3 | 73 | 3 | 18787174 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 26209274 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 24873968 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 22184329 | ||
| Pubmed | NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. | 8.87e-09 | 3 | 73 | 3 | 11018074 | |
| Pubmed | Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis. | 8.87e-09 | 3 | 73 | 3 | 33545139 | |
| Pubmed | Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. | 8.87e-09 | 3 | 73 | 3 | 20142487 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 9116268 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 20686129 | ||
| Pubmed | Angiotensin II induced catabolic effect and muscle atrophy are redox dependent. | 8.87e-09 | 3 | 73 | 3 | 21570954 | |
| Pubmed | p47(phox) contributes to albuminuria and kidney fibrosis in mice. | 8.87e-09 | 3 | 73 | 3 | 25565313 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 39357591 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 12958309 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 11435342 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 31118934 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 23482812 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 16041040 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 10085000 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 10987289 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 21435178 | ||
| Pubmed | Intermittent hypoxia has organ-specific effects on oxidative stress. | 8.87e-09 | 3 | 73 | 3 | 18703411 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 29228045 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 17307863 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 22155727 | ||
| Pubmed | Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss. | 8.87e-09 | 3 | 73 | 3 | 27829407 | |
| Pubmed | Mechanism of endoplasmic reticulum stress-induced vascular endothelial dysfunction. | 8.87e-09 | 3 | 73 | 3 | 24576409 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 22376231 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 23918780 | ||
| Pubmed | NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells. | 8.87e-09 | 3 | 73 | 3 | 28274989 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 26645958 | ||
| Pubmed | Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. | 8.87e-09 | 3 | 73 | 3 | 12364355 | |
| Pubmed | NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis. | 8.87e-09 | 3 | 73 | 3 | 24549323 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 34557202 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 28467721 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 10670582 | ||
| Pubmed | NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity. | 8.87e-09 | 3 | 73 | 3 | 20881184 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 26528554 | ||
| Pubmed | The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. | 8.87e-09 | 3 | 73 | 3 | 19052348 | |
| Pubmed | Effect of early particulate air pollution exposure on obesity in mice: role of p47phox. | 8.87e-09 | 3 | 73 | 3 | 20864666 | |
| Pubmed | Reactive oxygen species delay control of lymphocytic choriomeningitis virus. | 8.87e-09 | 3 | 73 | 3 | 23328631 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 34572995 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 17114280 | ||
| Pubmed | Participation of mitochondrial respiratory complex III in neutrophil activation and lung injury. | 8.87e-09 | 3 | 73 | 3 | 19168575 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 25989352 | ||
| Pubmed | NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. | 8.87e-09 | 3 | 73 | 3 | 19503084 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 17404617 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 17332431 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 36592568 | ||
| Pubmed | Genetic requirement of p47phox for superoxide production by murine microglia. | 8.87e-09 | 3 | 73 | 3 | 11156938 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 30504842 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 10772875 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 27798190 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 20702812 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 33705493 | ||
| Pubmed | Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. | 8.87e-09 | 3 | 73 | 3 | 23965970 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 26455429 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 15513930 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 15626477 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 15033459 | ||
| Pubmed | NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity. | 8.87e-09 | 3 | 73 | 3 | 19077231 | |
| Pubmed | Neutrophil-derived ROS contribute to oxidative DNA damage induction by quartz particles. | 8.87e-09 | 3 | 73 | 3 | 20828610 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 20817944 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 22319452 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 16895801 | ||
| Pubmed | Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. | 8.87e-09 | 3 | 73 | 3 | 20690191 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 16772302 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 32504071 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 16280459 | ||
| Pubmed | Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. | 8.87e-09 | 3 | 73 | 3 | 18185592 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 36853827 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 23024271 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 21253614 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 25873172 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 15310853 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 31393787 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 10725280 | ||
| Pubmed | Ncf1 Governs Immune Niches in the Lung to Mediate Pulmonary Inflammation in Mice. | 8.87e-09 | 3 | 73 | 3 | 34970267 | |
| Pubmed | Germ-free mice deficient of reactive oxygen species have increased arthritis susceptibility. | 8.87e-09 | 3 | 73 | 3 | 25689796 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 14993144 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 22050439 | ||
| Pubmed | The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. | 8.87e-09 | 3 | 73 | 3 | 12031896 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 11249873 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 15936744 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 17220182 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 25628043 | ||
| Pubmed | The p47phox mouse knock-out model of chronic granulomatous disease. | 8.87e-09 | 3 | 73 | 3 | 7650482 | |
| Pubmed | Disseminated trichosporonosis in a murine model of chronic granulomatous disease. | 8.87e-09 | 3 | 73 | 3 | 12868577 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 12560337 | ||
| Pubmed | NADPH oxidase mediates striatal neuronal injury after transient global cerebral ischemia. | 8.87e-09 | 3 | 73 | 3 | 20859296 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 35276443 | ||
| Pubmed | p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling. | 8.87e-09 | 3 | 73 | 3 | 16109921 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 19381132 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 16724810 | ||
| Cytoband | 7q11.23 | 5.11e-04 | 97 | 73 | 3 | 7q11.23 | |
| Cytoband | 22q11.21 | 7.56e-04 | 111 | 73 | 3 | 22q11.21 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.82e-03 | 34 | 42 | 2 | 487 | |
| GeneFamily | Proteasome | 4.48e-03 | 43 | 42 | 2 | 690 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 6.01e-03 | 50 | 42 | 2 | 1293 | |
| GeneFamily | AAA ATPases | 6.73e-03 | 53 | 42 | 2 | 413 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.96e-07 | 194 | 73 | 6 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.71e-07 | 197 | 73 | 6 | fa3cc33c975648172feabb485c3bdd087f1f8ea7 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 176 | 73 | 5 | 450c25ec5eeb65425f904e0a25aaafdf5682ef9c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 184 | 73 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 184 | 73 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 184 | 73 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 192 | 73 | 5 | 96f23d6e8604d1cb24910d3118d8171b57c93e14 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.68e-05 | 194 | 73 | 5 | 8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 195 | 73 | 5 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|COVID-19_Mild / Disease condition and Cell class | 1.76e-05 | 196 | 73 | 5 | 3729d1444c65cad640377894decc64129bc3fd5b | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.76e-05 | 196 | 73 | 5 | e4f40274df940e0996c555082f2bb4f99e5b0881 | |
| ToppCell | background-Kupffer_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.89e-05 | 199 | 73 | 5 | 91d229f3515d49639bcb5505e6aec4a9abade81c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT1-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-05 | 112 | 73 | 4 | 456278fb92dd41820fde8cf27c68fec45e15f972 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma-2|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 6.59e-05 | 132 | 73 | 4 | a8e7e7f38af095d63e221bcc06a1e5147bb6e467 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.20e-04 | 154 | 73 | 4 | 12cbc38bc1f7231c67e1d2d5e86e95bc12e24682 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.26e-04 | 156 | 73 | 4 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 160 | 73 | 4 | 41d6c811c445c0ba9b6a2deb10a3b6b793172582 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 160 | 73 | 4 | c1d03c0ac9c12615a06499209fcdf18e9b6f1fba | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-04 | 161 | 73 | 4 | d8140e7772b4e327dafa3536881a784d3c328d2a | |
| ToppCell | 5'-Adult-Appendix-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-04 | 164 | 73 | 4 | 29da0175bd3808a5b3039a6161c764105608ef96 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-04 | 164 | 73 | 4 | e83b632ac7e1dace946991ddfe1fbfbbffc3a88b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 164 | 73 | 4 | 2c929996a19bbe29949010928001c277b5494a42 | |
| ToppCell | TCGA-Colorectal|World / Sample_Type by Project: Shred V9 | 1.60e-04 | 166 | 73 | 4 | c018cd8c7a82251c67e3dc812d4d21e527a43456 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 167 | 73 | 4 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 170 | 73 | 4 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-04 | 171 | 73 | 4 | ef9397cec7f5c217d34583f26270af7ed7fbcebf | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-04 | 172 | 73 | 4 | 584af6537685cb459bf0fc298e6f46872016c116 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 176 | 73 | 4 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 176 | 73 | 4 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-04 | 176 | 73 | 4 | 1510cdfcfb46ce1196a1220c07fb5f3986c81b78 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-04 | 176 | 73 | 4 | 270d7908dbd84028958d257f94941dc685e20255 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-04 | 177 | 73 | 4 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 178 | 73 | 4 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-04 | 179 | 73 | 4 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | 15-Distal-Epithelial-Epithelial|Distal / Age, Tissue, Lineage and Cell class | 2.17e-04 | 180 | 73 | 4 | 99e2db9ad8e09fedc3542233553acece69f579f1 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 183 | 73 | 4 | 42dc31d587fbb9724b2f0be5ee8ed77233f67b86 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-04 | 183 | 73 | 4 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 184 | 73 | 4 | b998803180322a5ea2b567928dea531c26816c3c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.57e-04 | 188 | 73 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 188 | 73 | 4 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 188 | 73 | 4 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | cellseq-Immune-Hematopoietic-Granulocytic-Neutrophil|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.62e-04 | 189 | 73 | 4 | fedab592be1d6520325b8c1b659b0a4dc3f4fe4d | |
| ToppCell | (2)_NK/T-(210)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 2.62e-04 | 189 | 73 | 4 | fa72e87e1e8cd7cbddae7b47e19cf90d181820a7 | |
| ToppCell | (2)_NK/T-(21)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 2.62e-04 | 189 | 73 | 4 | b37ad24898a14a4a3b2d6cea2637de2471f76e20 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(II)|GI_large-bowel / Manually curated celltypes from each tissue | 2.67e-04 | 190 | 73 | 4 | fee64bacbb330d04dc1dc63909838f2c605d9f1f | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Naive_B_cells|bone_marrow / Manually curated celltypes from each tissue | 2.78e-04 | 192 | 73 | 4 | fa99243ff028498c6a67d207a93e02c48e69cd42 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 192 | 73 | 4 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | 21-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 2.83e-04 | 193 | 73 | 4 | 9a8bb44a37f3202e3123a6680bd5545dc91a6d40 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-04 | 194 | 73 | 4 | c9ebdcc2ea600975dade68a41fa65d1f8a5a5926 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-Naive_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 2.89e-04 | 194 | 73 | 4 | 20967afbadb3cf80ba9f4d7ebda4e64389252e70 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.95e-04 | 195 | 73 | 4 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-04 | 195 | 73 | 4 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B|bone_marrow / Manually curated celltypes from each tissue | 2.95e-04 | 195 | 73 | 4 | bcbf0305ca9337a6f3021178dbb47a7fbf1030a4 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.01e-04 | 196 | 73 | 4 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.01e-04 | 196 | 73 | 4 | 45d1c0a962c4221c17393ee5566961d1deebf442 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 3.06e-04 | 197 | 73 | 4 | e666f6580e9a20b5e550f02125706db17eec8510 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-04 | 197 | 73 | 4 | 0523aec9713ae21e6b879aa98e07fa2576610d5f | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 197 | 73 | 4 | d9978aaa476b57144b0561f535ff1dd886c7512b | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-04 | 197 | 73 | 4 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.06e-04 | 197 | 73 | 4 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-04 | 197 | 73 | 4 | 61ef3f417767c3f5296a26399da63e3e4f58faf8 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 3.06e-04 | 197 | 73 | 4 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.12e-04 | 198 | 73 | 4 | d347462ba6cb1c5a59c86dffbbe914cbc1e9cf16 | |
| ToppCell | Multiple_Sclerosis-Myeloid|Multiple_Sclerosis / Disease, Lineage and Cell Type | 3.12e-04 | 198 | 73 | 4 | 3c2817d95011ae372d0316ccf774e975536207b0 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.12e-04 | 198 | 73 | 4 | ed86b0247006befe55400c287d334d2202b470bd | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.12e-04 | 198 | 73 | 4 | c5a22846bccff948f90bc1d5fe309907dcd08348 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.12e-04 | 198 | 73 | 4 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | COVID-19_Mild-Myeloid-Classical_Monocyte|COVID-19_Mild / Disease group, lineage and cell class | 3.12e-04 | 198 | 73 | 4 | e78d027a095473af555762a4d542a73f5bb2e166 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.12e-04 | 198 | 73 | 4 | 06201b34d3e38f22c93b759511f7b376504bac06 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|COVID-19_Convalescent / Disease condition and Cell class | 3.12e-04 | 198 | 73 | 4 | f65fd9b773aeafa55e38309479954a8e41371f52 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.12e-04 | 198 | 73 | 4 | c49c71b34151d82b8795763bcb633c301c35f659 | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.12e-04 | 198 | 73 | 4 | a35b43d38e18c6f8f0cd9015b8e23f71c729f023 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.12e-04 | 198 | 73 | 4 | 4780f0276546962a2fc9f1041cfe49d2919d72b2 | |
| ToppCell | Multiple_Sclerosis-Myeloid-CD14_Mono|Multiple_Sclerosis / Disease, Lineage and Cell Type | 3.12e-04 | 198 | 73 | 4 | 128969698b2b0468cf5374f695e2d9fd02227d13 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.12e-04 | 198 | 73 | 4 | 1ca91559fef231896e16180f5e050155c38f7cfa | |
| ToppCell | distal-3-Hematologic-Interstitial_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.12e-04 | 198 | 73 | 4 | 137a786da9f54b4f17e385a675d50a37de88f1b5 | |
| ToppCell | IIF-Myeloid-CD14_Mono|IIF / Disease, Lineage and Cell Type | 3.18e-04 | 199 | 73 | 4 | accfb3d8ad3f03f9302f2056ca16c1be6231a351 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.18e-04 | 199 | 73 | 4 | ce699726ac4825c65bf934cb9a76202ad7340596 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.18e-04 | 199 | 73 | 4 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | healthy_donor-Myeloid-Monocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.18e-04 | 199 | 73 | 4 | bd66a8d1a7cc92313328acc7c7ae0442faff951e | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 3.18e-04 | 199 | 73 | 4 | dee1cf8ee850a2bd57349418a9bcc0948fe9ac9e | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1+SPP1+|Mild / Condition, Lineage, Cell class and cell subclass | 3.18e-04 | 199 | 73 | 4 | 2cbaef86af870a228cb46895dd765ea8894c83c5 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 3.18e-04 | 199 | 73 | 4 | 3feee9f53860b4b2e93ff2360beb2b2b74f51d24 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-04 | 199 | 73 | 4 | 841338719d042247966867ac608146395eb8c4d9 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.18e-04 | 199 | 73 | 4 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 3.24e-04 | 200 | 73 | 4 | 617a6a42f7b31eb3c45bdceaf55a591b6de7f154 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-T/NK_proliferative|Int-URO / Disease, condition lineage and cell class | 3.24e-04 | 200 | 73 | 4 | 99acc1ea01288efdd5b166aa20d66735f2bbe543 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.24e-04 | 200 | 73 | 4 | f7c3a8f5ac156c05ad7335d6d142c154c7d86449 | |
| ToppCell | 10x_3'_v2v3-Neoplastic|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.24e-04 | 200 | 73 | 4 | e9c7d7cb5fa63fc92aa91d02ae8bd05438d465bc | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.24e-04 | 200 | 73 | 4 | 2afbb5b5742b956993796621fea7e0c9888754a1 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.24e-04 | 200 | 73 | 4 | 4462ebd5d4632788f10a93fadd2babae701c754f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.24e-04 | 200 | 73 | 4 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 3.24e-04 | 200 | 73 | 4 | fec2660c9a9977b3b3a2eaed063b9049c0b07ff2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.24e-04 | 200 | 73 | 4 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| Drug | 3-acetylisoquinoline | 5.53e-07 | 6 | 70 | 3 | CID000124656 | |
| Drug | AC1L2O7O | 9.32e-06 | 2 | 70 | 2 | CID000075180 | |
| Drug | tris(tetrabutylammonium) hydrogen pyrophosphate | 9.32e-06 | 2 | 70 | 2 | CID011115639 | |
| Drug | 2-amino-1-hydroxyguanidine | 9.32e-06 | 2 | 70 | 2 | CID005464082 | |
| Drug | SureCN843110 | 9.32e-06 | 2 | 70 | 2 | CID014570995 | |
| Drug | v 1394 | 9.32e-06 | 2 | 70 | 2 | CID000101484 | |
| Drug | Adenosine phosphonoacetic acid | 2.79e-05 | 3 | 70 | 2 | CID000448505 | |
| Drug | AC1N8OVF | 2.79e-05 | 3 | 70 | 2 | CID004347182 | |
| Drug | 2'-deoxytoyocamycin | 2.79e-05 | 3 | 70 | 2 | CID000204132 | |
| Drug | 2'-chloro-2'-dudp | 2.79e-05 | 3 | 70 | 2 | CID003082518 | |
| Drug | 1-amino-3-hydroxyguanidine | 2.79e-05 | 3 | 70 | 2 | CID009571038 | |
| Drug | Bild 1351 | 2.79e-05 | 3 | 70 | 2 | CID005478827 | |
| Drug | beta-dimethylaminopropiophenone | 2.79e-05 | 3 | 70 | 2 | CID000077042 | |
| Drug | 3,4-dihydroxybenzaldoxime | 2.79e-05 | 3 | 70 | 2 | CID005388593 | |
| Drug | hydroxyguanidine sulfate | 2.79e-05 | 3 | 70 | 2 | CID000080667 | |
| Drug | 2D ABR | 2.79e-05 | 3 | 70 | 2 | CID000125209 | |
| Drug | NSC-137029 | 2.79e-05 | 3 | 70 | 2 | CID000421633 | |
| Drug | Bild 1357 | 2.79e-05 | 3 | 70 | 2 | CID000515298 | |
| Drug | 2'-azido-2'-deoxycytidine 5'-diphosphate | 2.79e-05 | 3 | 70 | 2 | CID000170963 | |
| Drug | AC1LAKEY | 2.79e-05 | 3 | 70 | 2 | CID000515340 | |
| Drug | Val-Val-Asn-Asp-Leu | 2.79e-05 | 3 | 70 | 2 | CID000515343 | |
| Drug | 6-aminothymine | 2.79e-05 | 3 | 70 | 2 | CID000065245 | |
| Drug | dial-CDP | 2.79e-05 | 3 | 70 | 2 | CID005487791 | |
| Drug | cyclo(Sar-Sar | 2.79e-05 | 3 | 70 | 2 | CID000078761 | |
| Drug | Tenoxicam [59804-37-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 4182_DN | |
| Drug | 2-formylpyridine thiosemicarbazonato copper(II | 5.57e-05 | 4 | 70 | 2 | CID009576822 | |
| Drug | 4-nitro-benzohydrazide | 5.57e-05 | 4 | 70 | 2 | CID003693744 | |
| Drug | AC1O7EGN | 5.57e-05 | 4 | 70 | 2 | CID006446439 | |
| Drug | BPYTA | 5.57e-05 | 4 | 70 | 2 | CID003034633 | |
| Drug | 2-formylpyridine thiosemicarbazone | 5.57e-05 | 4 | 70 | 2 | CID001638752 | |
| Drug | p-propoxyphenol | 5.57e-05 | 4 | 70 | 2 | CID000029352 | |
| Drug | Dacisteine | 5.57e-05 | 4 | 70 | 2 | CID000065690 | |
| Drug | 2'-azido-2'-deoxyuridine | 5.57e-05 | 4 | 70 | 2 | CID000168629 | |
| Drug | motropin | 9.26e-05 | 5 | 70 | 2 | CID000064657 | |
| Drug | AC1NQVLK | 9.26e-05 | 5 | 70 | 2 | CID002732427 | |
| Drug | A1110U | 9.26e-05 | 5 | 70 | 2 | CID003006964 | |
| Drug | 2-methylene-3-furanone | 9.26e-05 | 5 | 70 | 2 | CID000124504 | |
| Drug | 348U87 | 9.26e-05 | 5 | 70 | 2 | CID003006985 | |
| Drug | 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone | 9.26e-05 | 5 | 70 | 2 | CID005384003 | |
| Drug | p-butoxyphenol | 9.26e-05 | 5 | 70 | 2 | CID000031233 | |
| Drug | mdGuo | 9.26e-05 | 5 | 70 | 2 | CID000126596 | |
| Drug | bruceine | 9.26e-05 | 5 | 70 | 2 | CID000122785 | |
| Drug | acetylpyrazine | 9.26e-05 | 5 | 70 | 2 | CID000030914 | |
| Drug | MdAdo | 9.26e-05 | 5 | 70 | 2 | CID000175972 | |
| Drug | N-hydroxy-N'-methylurea | 9.26e-05 | 5 | 70 | 2 | CID000096412 | |
| Drug | Citrusinine-I | 9.26e-05 | 5 | 70 | 2 | CID005487772 | |
| Drug | 2-acetylpyridine | 9.60e-05 | 29 | 70 | 3 | CID000014286 | |
| Drug | aucubin | 9.60e-05 | 29 | 70 | 3 | CID000091458 | |
| Drug | VF 122 | 1.39e-04 | 6 | 70 | 2 | CID000100590 | |
| Drug | MK-410 | 1.39e-04 | 6 | 70 | 2 | CID006451644 | |
| Drug | Tdho | 1.39e-04 | 6 | 70 | 2 | CID003037009 | |
| Drug | 2'-chloro-2'-deoxyadenosine | 1.39e-04 | 6 | 70 | 2 | CID000100327 | |
| Drug | EHNA | 1.50e-04 | 87 | 70 | 4 | CID000003206 | |
| Drug | S)-HPMPA | 1.85e-04 | 36 | 70 | 3 | CID000072253 | |
| Drug | monomethyl azelate | 1.94e-04 | 7 | 70 | 2 | CID000075009 | |
| Drug | Thiram | 2.26e-04 | 533 | 70 | 8 | ctd:D013893 | |
| Drug | GC Q | 2.58e-04 | 8 | 70 | 2 | CID006420157 | |
| Drug | parabactin | 2.58e-04 | 8 | 70 | 2 | CID005487017 | |
| Drug | B Hm | 2.58e-04 | 8 | 70 | 2 | CID000100038 | |
| Drug | hydroxamate 11 | 2.58e-04 | 8 | 70 | 2 | CID010001582 | |
| Drug | AC1MHU3O | 2.58e-04 | 8 | 70 | 2 | CID003032423 | |
| Drug | N3UDP | 2.58e-04 | 8 | 70 | 2 | CID000169817 | |
| Drug | biochanin A | 2.67e-04 | 101 | 70 | 4 | CID005280373 | |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; HL60; HG-U133A | 3.14e-04 | 192 | 70 | 5 | 1365_DN | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 3.22e-04 | 193 | 70 | 5 | 4173_DN | |
| Drug | STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 6583_UP | |
| Drug | PHA-00767505E [723337-45-9]; Down 200; 10uM; PC3; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 6591_DN | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 4151_DN | |
| Drug | Bezafibrate [41859-67-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.54e-04 | 197 | 70 | 5 | 2630_UP | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.54e-04 | 197 | 70 | 5 | 3531_UP | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 1uM; PC3; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 4333_UP | |
| Drug | Dydrogesterone [152-62-5]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 4836_UP | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 1.19e-08 | 12 | 67 | 4 | DOID:7148 (implicated_via_orthology) | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 1.12e-07 | 5 | 67 | 3 | DOID:3265 (implicated_via_orthology) | |
| Disease | C-X-C motif chemokine 6 measurement | 6.13e-06 | 16 | 67 | 3 | EFO_0008059 | |
| Disease | HIV Coinfection | 9.06e-05 | 103 | 67 | 4 | C4505456 | |
| Disease | HIV Infections | 9.06e-05 | 103 | 67 | 4 | C0019693 | |
| Disease | Sjogren's Syndrome | 3.90e-04 | 13 | 67 | 2 | C1527336 | |
| Disease | Sicca Syndrome | 3.90e-04 | 13 | 67 | 2 | C0086981 | |
| Disease | level of C-X-C motif chemokine 3 in blood serum | 5.23e-04 | 15 | 67 | 2 | OBA_2041208 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 6.15e-04 | 301 | 67 | 5 | DOID:684 (is_marker_for) | |
| Disease | Leukemia, Myelocytic, Acute | 6.56e-04 | 173 | 67 | 4 | C0023467 | |
| Disease | Carcinoma of lung | 1.25e-03 | 23 | 67 | 2 | C0684249 | |
| Disease | Acute monocytic leukemia | 1.59e-03 | 26 | 67 | 2 | C0023465 | |
| Disease | systemic scleroderma, systemic lupus erythematosus | 1.59e-03 | 26 | 67 | 2 | EFO_0000717, MONDO_0007915 | |
| Disease | Sezary Syndrome | 1.72e-03 | 27 | 67 | 2 | C0036920 | |
| Disease | Iniencephaly | 1.85e-03 | 28 | 67 | 2 | C0152234 | |
| Disease | Tethered Cord Syndrome | 1.85e-03 | 28 | 67 | 2 | C0080218 | |
| Disease | Spinal Cord Myelodysplasia | 1.85e-03 | 28 | 67 | 2 | C0344479 | |
| Disease | Exencephaly | 1.85e-03 | 28 | 67 | 2 | C0266453 | |
| Disease | Neurenteric Cyst | 1.85e-03 | 28 | 67 | 2 | C0027806 | |
| Disease | Acrania | 1.85e-03 | 28 | 67 | 2 | C0702169 | |
| Disease | Diastematomyelia | 1.85e-03 | 28 | 67 | 2 | C0011999 | |
| Disease | Craniorachischisis | 1.98e-03 | 29 | 67 | 2 | C0152426 | |
| Disease | Strabismus | 1.98e-03 | 29 | 67 | 2 | HP_0000486 | |
| Disease | Neural Tube Defects | 2.12e-03 | 30 | 67 | 2 | C0027794 | |
| Disease | mean reticulocyte volume | 2.21e-03 | 799 | 67 | 7 | EFO_0010701 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HKERWLAKQWTLVSE | 451 | Q9ULK5 | |
| ILDTHWELWKKTHRK | 21 | P43235 | |
| LAIKKLHSWLKDWKR | 1071 | Q96QE3 | |
| KWLKLWDLVVFGHER | 306 | Q8WVB6 | |
| IKSTREEKEWWIRSK | 601 | Q5VTM2 | |
| RKKDPVLLLHWWKEI | 511 | Q9NZJ5 | |
| WLARWKREAEKKAKV | 206 | Q9Y6K1 | |
| TVKKAREAWKIWADI | 91 | P49419 | |
| VWKKWQLTKGLRDVA | 1471 | Q8N7X0 | |
| DKKHVDWVKAYLSIW | 176 | Q01518 | |
| LVHKWAWTKDDVILH | 226 | Q4G176 | |
| AWLSWETKKKNVLHL | 136 | Q13536 | |
| WENDWLKKEVAIHRK | 216 | Q8IWF9 | |
| WWVSKHIKKPIRSTV | 131 | Q92747 | |
| KIWLAAHWEKKLTKA | 16 | Q9H4I0 | |
| KIWLAAHWDKKLTKA | 16 | O60216 | |
| HELIKLNWLLAKALW | 371 | A6NNM3 | |
| HELIKLNWLLAKALW | 371 | A6NJZ7 | |
| KILETWGELLSKWHL | 536 | Q9Y3P9 | |
| IEAWKAAEKKARWVL | 26 | Q8IV08 | |
| KWKKWSIHIVIPKGT | 4356 | Q8NEZ4 | |
| KPIDWLLDHILWVKV | 326 | Q9UQ53 | |
| LRNKDVKGALWKVLW | 291 | Q8NGV0 | |
| IHKLLDGWWVIRKDD | 256 | P14598 | |
| KLEVLDHSKRWWLVK | 476 | Q8TE67 | |
| QHWAKSEKVKLWEVS | 136 | Q9NYR9 | |
| LWETRVKKHKAWQKK | 16 | Q9BYS8 | |
| GLLLWQSWLELKKMH | 181 | Q9BY08 | |
| VWHRLEELYTKKLWH | 21 | Q9UNM6 | |
| KWEEIKKLKASLWAL | 916 | Q6R327 | |
| VIHKLLDGWWVIRKD | 256 | A6NI72 | |
| VIHKLLDGWWVIRKD | 231 | A8MVU1 | |
| LEKLKERWLSTGLWH | 701 | Q9BX63 | |
| LWWAAKELRRTKKLS | 191 | P57076 | |
| KTDHLSWEWNLTIKK | 186 | P52565 | |
| IWKKRWDKFIADVAT | 496 | Q9NZK5 | |
| KVLEEHGEWWKAKSL | 91 | P07948 | |
| HGEWWKAKSLLTKKE | 96 | P07948 | |
| HTVVLWDWKKGEKLS | 796 | Q05BV3 | |
| LILVCAWHWRNRKKK | 546 | Q96PD2 | |
| QAWKEVRLHKTTWLR | 66 | Q9H6D7 | |
| LLLLQKKEWTWDESK | 91 | O75052 | |
| EKKRTWLLKTHWTLD | 66 | Q96AC1 | |
| LQEEDKLHIMKEKWW | 786 | Q13003 | |
| RTVKKEWQAAWLLKA | 36 | Q9Y315 | |
| VKRAELWDTWKVAHL | 231 | Q9BVI4 | |
| WRKTLRAKKGEHIWI | 2321 | Q8TE73 | |
| KWILSEKEWEREKAV | 956 | A6NES4 | |
| KGEFVWKSHKWDREL | 71 | P02790 | |
| ELKEENRTLWWKKLL | 926 | Q969F9 | |
| HELIKLNWLLAKALW | 371 | Q9UFD9 | |
| IKDWTKEHVKKWVNE | 11 | Q8IVG5 | |
| LWSWMKLETIILSKL | 151 | Q9H606 | |
| LLSWKLERVFKDWAK | 141 | Q9UJQ7 | |
| GSDNLLVILKRKWWK | 96 | Q8IXU6 | |
| HELNLARKMREWKLW | 86 | Q16718 | |
| KPWKVHVKWILDTDI | 261 | Q92922 | |
| KKIEELKAHWKWEQV | 291 | Q9H7B4 | |
| HVKNWWKKKEEHPIL | 176 | O43704 | |
| LRKWSHSLQKRWIEV | 291 | Q86WD7 | |
| IHILKIMWKWIGELQ | 896 | A8K7I4 | |
| KKKADWALRWIADRK | 166 | Q7LG56 | |
| AIMEHKELLKVPWDW | 266 | Q5T1Q4 | |
| TDLWDWKVLKEKIAK | 576 | P23921 | |
| DKHITIEDLWKRWKT | 116 | Q9P246 | |
| WTWLEAILDLIKKHI | 551 | Q14765 | |
| RKLLWAIHHWKKIKK | 226 | Q8TC07 | |
| KHWTFEKVEKLWELL | 1391 | Q14997 | |
| GKFLLKVDSKLWHWL | 431 | Q9H330 | |
| SWIKWLKEILECSHL | 376 | Q7Z2W7 | |
| KLEKETIIWRTKWEN | 391 | Q9NUQ3 | |
| ILVILKEWTSKLWHR | 61 | Q96GC9 | |
| VWIKSLSWLHRKLEQ | 751 | P57678 | |
| WLRTDKDWKAGKTKI | 731 | Q6PIF6 |